﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/caplin-point-receives-eir-from-fda-with-zero-483-observations-16626</loc><lastmod>2025-01-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/sentynl-therapeutics-receives-usfda-acceptance-and-priority-review-of-new-drug-application-for-cutx-101-product-candidate-for-treatment-of-menkes-disease-16627</loc><lastmod>2025-01-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/sai-ramana-ponugoti-appointed-as-ceo-ich-of-piramal-pharma-16628</loc><lastmod>2025-01-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/quality-not-just-a-measure-a-way-of-life-that-drives-innovation-renewable-energy-minister-joshi-16629</loc><lastmod>2025-01-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/148-lakh-new-tb-cases-identified-in-the-first-30-days-of-tb-mukt-bharat-100-days-intensified-campaign-16630</loc><lastmod>2025-01-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/nutraceuticals-cdmo-manufacturer-crius-group-to-adopt-100-ai-based-project-implementation-16631</loc><lastmod>2025-01-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/zydus-inks-agreement-with-cvs-caremark-to-add-zituvio-zituvimet-and-zituvimet-xr-to-its-template-formulary-16632</loc><lastmod>2025-01-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/japan-health-authority-approves-biocon-biologics-ustekinumab-bs-biosimilar-to-jjs-stelara-16633</loc><lastmod>2025-01-07T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>